Healthy volunteers help scientists track RE104's path through the body
NCT ID NCT07146191
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 39 times
Summary
This study involved 8 healthy adults aged 18–55 who received a single tiny dose of RE104, a drug with psychoactive properties. Researchers measured how much of the drug appeared in blood, urine, and stool over at least a week to understand how the body absorbs, breaks down, and gets rid of it. The goal was purely to gather information about the drug's metabolism, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Inc.
Austin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.